Psyros Diagnostics was established to realise our vision of transforming patients’ lives by ensuring they get the right test at the right time for the right diagnosis. We are developing a next-generation point-of-care testing system and central to our vision is significantly improving analytical sensitivity over currently available point-of-care tests. We have developed proprietary ground-breaking novel assay technology that exploits digital single-molecule counting, enabling us to achieve femtomolar detection levels. This capability opens up numerous rapid and critical decision-making tests at the patient’s bedside that was previously only possible in specialised laboratories. We believe this will transform patient management in several key clinical settings.
Contact: enquiries@psyrosdiagnostics.com
